Items where Author is "Renner, C."

2010

Taverna, C. and Bargetzi, M. and Betticher, D. and Gmür, J. and Gregor, M. and Heim, D. and Hess, U. and Ketterer, N. and Lerch, E. and Matthes, T. and Mey, U. and Pabst, T. and Renner, C.. (2010) Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations. Swiss Medical Weekly, Vol. 140 , w13054.

2008

Tinguely, M. and Jenni, B. and Knights, A. and Lopes, B. and Korol, D. and Rousson, V. and Curioni Fontecedro, A. and Cogliatti, S. B. and Bittermann, A. G. and Schmid, U. and Dommann-Scherrer, C. and Maurer, R. and Renner, C. and Probst-Hensch, N. M. and Moch, H. and Knuth, A. and Zippelius, A.. (2008) MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer science, Vol. 99, H. 4. pp. 720-725.

Curioni-Fontecedro, A. and Knights, A. J. and Tinguely, M. and Nuber, N. and Schneider, C. and Thomson, C. W. and von Boehmer, L. and Bossart, W. and Pahlich, S. and Gehring, H. and Moch, H. and Renner, C. and Knuth, A. and Zippelius, A.. (2008) MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, Vol. 22, no. 8. pp. 1646-1648.

2004

Pokidysheva, E. and Milbradt, A. G. and Meier, S. and Renner, C. and Haussinger, D. and Bachinger, H. P. and Moroder, L. and Grzesiek, S. and Holstein, T. W. and Ozbek, S. and Engel, J.. (2004) The structure of the Cys-rich terminal domain of Hydra minicollagen, which is involved in disulfide networks of the nematocyst wall. Journal of biological chemistry, Vol. 279 , no. 29. pp. 30395-30401.